629 related articles for article (PubMed ID: 22025199)
1. Heterometallic platinum(II) compounds with β-aminoethylferrocenes: synthesis, electrochemical behaviour and anticancer activity.
Nieto D; González-Vadillo AM; Bruña S; Pastor CJ; Ríos-Luci C; León LG; Padrón JM; Navarro-Ranninger C; Cuadrado I
Dalton Trans; 2012 Jan; 41(2):432-41. PubMed ID: 22025199
[TBL] [Abstract][Full Text] [Related]
2. Diastereomerically pure platinum(II) complexes as antitumoral agents.: The influence of the mode of binding {(N), (N,O)- or (C,N)}- of (1S,2R)[(η5-C5H5)Fe{(η5-C5H4)CHNCH(Me)CH(OH)C6H5}] and the arrangement of the auxiliary ligands.
Talancón D; López C; Font-Bardía M; Calvet T; Quirante J; Calvis C; Messeguer R; Cortés R; Cascante M; Baldomà L; Badia J
J Inorg Biochem; 2013 Jan; 118():1-12. PubMed ID: 23123334
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
[TBL] [Abstract][Full Text] [Related]
4. Complexes of platinum(II) containing neutral and deprotonated 9-methyladenine. Synthesis, x-ray structures, and NMR studies on the cyclic trimer cis-[L2Pt[9-MeAd([bond]H)]]3(NO3)3 and the Dinuclear cis-[L2Pt(ONO2)[9-MeAd([bond]H)]PtL2](NO3)2 (L = PMePh2).
Longato B; Pasquato L; Mucci A; Schenetti L; Zangrando E
Inorg Chem; 2003 Dec; 42(24):7861-71. PubMed ID: 14632502
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic insight into protonolysis and cis-trans isomerization of benzylplatinum(II) complexes assisted by weak ligand-to-metal interactions. A combined kinetic and DFT study.
Guido E; D'Amico G; Russo N; Sicilia E; Rizzato S; Albinati A; Romeo A; Plutino MR; Romeo R
Inorg Chem; 2011 Mar; 50(6):2224-39. PubMed ID: 21341750
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, crystal structure, studies in solution and cytotoxicity of two new fluorescent platinum(II) compounds containing anthracene derivatives as a carrier ligand.
Marqués-Gallego P; den Dulk H; Brouwer J; Kooijman H; Spek AL; Roubeau O; Teat SJ; Reedijk J
Inorg Chem; 2008 Dec; 47(23):11171-9. PubMed ID: 18975941
[TBL] [Abstract][Full Text] [Related]
7. Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity.
Starha P; Trávnícek Z; Popa I
J Inorg Biochem; 2010 Jun; 104(6):639-47. PubMed ID: 20304500
[TBL] [Abstract][Full Text] [Related]
8. Neutral and ionic platinum compounds containing a cyclometallated chiral primary amine: synthesis, antitumor activity, DNA interaction and topoisomerase I-cathepsin B inhibition.
Albert J; Bosque R; Crespo M; Granell J; López C; Martín R; González A; Jayaraman A; Quirante J; Calvis C; Badía J; Baldomà L; Font-Bardia M; Cascante M; Messeguer R
Dalton Trans; 2015 Aug; 44(30):13602-14. PubMed ID: 26140359
[TBL] [Abstract][Full Text] [Related]
9. Mono- and dinuclear platinum(II) compounds with 5,7-dimethyl-1,2,4-triazolo[1,5-a]pyrimidine. Structure, cytotoxic activity and reaction with 5'-GMP.
Łakomska I; Kooijman H; Spek AL; Shen WZ; Reedijk J
Dalton Trans; 2009 Dec; (48):10736-41. PubMed ID: 20023903
[TBL] [Abstract][Full Text] [Related]
10. Quinoxaline-2-carboxamide as a carrier ligand in two new platinum(II) compounds: Synthesis, crystal structure, cytotoxic activity and DNA interaction.
Marqués-Gallego P; Gamiz-Gonzalez MA; Fortea-Pérez FR; Lutz M; Spek AL; Pevec A; Kozlevčar B; Reedijk J
Dalton Trans; 2010 Jun; 39(21):5152-8. PubMed ID: 20419195
[TBL] [Abstract][Full Text] [Related]
11. Acetonimine and 4-imino-2-methylpentan-2-amino platinum(II) complexes: synthesis and in vitro antitumor activity.
Ruiz J; Rodríguez V; Cutillas N; López G; Bautista D
Inorg Chem; 2008 Nov; 47(21):10025-36. PubMed ID: 18844342
[TBL] [Abstract][Full Text] [Related]
12. Crystal structures and cytotoxicity of isopropylamine Pt(II) complexes: a trinuclear squarato-bridged [Pt3(mu2-C4O4)3(H2NPri)6].3H2O and a mononuclear cis-[Pt(NO3)2(H2NPri)2].
Grabner S; Modec B; Cemazar M; Bukovec N
J Inorg Biochem; 2005 Jul; 99(7):1465-71. PubMed ID: 15927264
[TBL] [Abstract][Full Text] [Related]
13. Atropisomerization, C-H activation, and dissociative substitution at some biphenyl platinum(II) complexes.
Plutino MR; Scolaro LM; Albinati A; Romeo R
J Am Chem Soc; 2004 May; 126(20):6470-84. PubMed ID: 15149244
[TBL] [Abstract][Full Text] [Related]
14. Platinum(II) and palladium(II) complexes with (N,N') and (C,N,N')- ligands derived from pyrazole as anticancer and antimalarial agents: synthesis, characterization and in vitro activities.
Quirante J; Ruiz D; Gonzalez A; López C; Cascante M; Cortés R; Messeguer R; Calvis C; Baldomà L; Pascual A; Guérardel Y; Pradines B; Font-Bardía M; Calvet T; Biot C
J Inorg Biochem; 2011 Dec; 105(12):1720-8. PubMed ID: 22104300
[TBL] [Abstract][Full Text] [Related]
15. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
Roy S; Westmaas JA; Buda F; Reedijk J
J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
[TBL] [Abstract][Full Text] [Related]
16. Relevance of the leaving group for antitumor activity of new platinum(II) compounds containing anthracene derivatives as a carrier ligand.
Marqués-Gallego P; Contaldi S; den Dulk H; Monari M; Brouwer J; Jaehde U; Kalayda GV; Reedijk J
J Inorg Biochem; 2009 Dec; 103(12):1602-8. PubMed ID: 19783310
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
[TBL] [Abstract][Full Text] [Related]
18. Platinum complexes with 5-methyl-5(4-pyridyl)hydantoin and its 3-methyl derivatives: synthesis and cytotoxic activity - quantitative structure-activity relationships.
Bakalova A; Varbanov H; Buyukliev R; Momekov G; Ivanov D; Doytchinova I
Arch Pharm (Weinheim); 2011 Apr; 344(4):209-16. PubMed ID: 21469169
[TBL] [Abstract][Full Text] [Related]
19. Structure and dynamics of methyl cis-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside complexes with PtCl(2) and PdCl(2), by (1)H, (2)H, (13)C, (15)N and (195)Pt NMR spectroscopy in DMSO, CD(3)CN and H(2)O.
Bednarek E; Sitkowski J; Kawecki R; Kozerski L; Bocian W; Pazderski L; Priebe W
Dalton Trans; 2008 Aug; (31):4129-37. PubMed ID: 18688431
[TBL] [Abstract][Full Text] [Related]
20. Remarkable anticancer activity of ferrocenyl-terpyridine platinum(ii) complexes in visible light with low dark toxicity.
Mitra K; Basu U; Khan I; Maity B; Kondaiah P; Chakravarty AR
Dalton Trans; 2014 Jan; 43(2):751-63. PubMed ID: 24149439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
